Portfolio

Cerulean Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the design and development of nanopharmaceuticals.

Aveo Pharmaceuticals integrates a proprietary cancer biology platform with drug development and commercial expertise in its efforts to discover and develop targeted cancer therapeutics.

World’s leading provider of employer-sponsored child care, early education and work/life solutions.

Allscripts provides innovative solutions such as Electronic Medical Records (EMRs) that empower all stakeholders across the healthcare continuum to deliver world-class outcomes. The company went public in July 1999 (NASDAQ:MDRX).

Develops non-systemic, protein therapeutics to treat metabolic and inflammatory diseases. In 2010 it was acquired by Eli Lilly and Company (NYSE:LLY).

A biopharmaceutical firm developing enzymes that activate our natural defenses against disease.

Used high-throughput computer screening to develop drugs more quickly.

The trusted partner for health and human services' largest connected community of providers and payers, Netsmart provides comprehensive financial, clinical and management solutions for healthcare delivery organizations. In June 2010 it was acquired by Genstar Capital.

MediAssist is a Third Party Administrator of health insurance policies.

NephroPlus is a well established chain of kidney care clinics that is shaping quality kidney care all over India.

A biopharmaceutical company developing novel therapeutics to modulate the growth of tissues including bone and muscle.

Allena Pharmaceuticals, Inc. is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

Proteon Therapeutics, Inc is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with renal and vascular diseases.

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. In January 2012, Verastem went public (NASDAQ: VSTM).

Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions.  Affymax (NASDAQ: AFFY) went public in 2006.

Liazon is the leading private benefit exchange provider for small and medium sized businesses.

Health Essentials provides post-acute care management services.

DocuTAP provides electronic medical record, practice management software and revenue cycle services for urgent care centers.

A web-based healthcare information exchange platform which enables reliable,speedy and transparent payer-provider workflow.

Stromedix's initial focus is on chronic indications and plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer.  In 2012, Stromedix was acquired by Biogen Idec (NASDAQ: BIIB).

On-Q-ity is a next-generation diagnostics company focused on transforming cancer treatment and improving treatment outcomes for cancer patients.

OvaSciences is a healthcare company focused on improving fertility. Ovascience (NASDAQ: OVAS) started trading on the Over The Counter Bulletin Board (OTCBB) in November 2012 and listed on the Nasdaq in April 2013.

Isis is the leader in antisense drug development with a broad pipeline of drugs that are applicable to many different disease targets.

Provides a comparison platform to help customers find affordable health insurance.

Oxagen is focused on becoming a significant biopharmaceutical company, developing a pipeline of novel drugs to treat inflammatory diseases, initially asthma.

AccuVein is a medical device company that uses optical technology to help facilitate venous access. It operates the world's only handheld, non-contact vein illumination solution and is used in over 700 hospitals today.

A leading hospice care provider.

IPC is the nation's leading national physician group practice focused on the delivery of hospital medicine and related facility-based services.

Developed and manufactured an integrated system that reduced the time and cost of drug discoveries.

Produced proprietary drug-delivery technology for the development of safe and practical biopharmaceuticals.

Develops software and services that streamline  lab-supply purchases and lab-operations management.

Insmed Incorporated (NASDAQ: INSM) is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery.

TravCorps provides healthcare professionals for temporary and permanent assignments. Today, TravCorps provides registered nurses to more than 2,500 healthcare facilities across the U.S. and the Caribbean.

Manufacturer of computer-based medical diagnostic equipment.

EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005.

Developed mechanisms to deliver smaller doses of drugs specifically to their targets.

Develops imaging agents for use in MRIs.

Developed software that facilitated the medical insurance payment process by translating medical terms into codes.

Headquartered in Waltham, MA, Fractyl Laboratories is an exciting new medical device startup that is focused on developing innovative solutions to chronic diseases.

An investor in biotech companies.

Developer of anti-viral, anti-bacterial and anti-cancer compounds.

Developer of innovative therapeutics.

Maker of food additives founded in 1987 as part of Enzytech, a biopharmaceutical research company.

Medical-device manufacturer.